Limited-time offer: 25% lower prices on injectable GLP-1
Limited-time offer: 25% lower prices on injectable GLP-1
Limited-time offer: 25% lower prices on injectable GLP-1
Limited-time offer: 25% lower prices on injectable GLP-1
AMQ-005-3V

5-Amino-1MQ

PLP Growth Research Peptide is a premium-quality research compound manufactured to high purity standards. Designed for laboratory and scientific research applications

In Stock

Made in USA

Endotoxin free

Purity ≥99%

USP standards

Description

5-Amino-1-methylquinolinium (5-Amino-1MQ) is a potent small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme implicated in metabolic dysfunction and adipogenesis. By suppressing NNMT activity, 5-Amino-1MQ helps restore cellular NAD+ availability and supports healthy mitochondrial energy metabolism. Research suggests it may play a role in reducing fat cell differentiation, improving insulin sensitivity, and promoting favorable changes in body composition — making it of significant interest in metabolic and longevity research.

Pricing Schedule

1-49 units

AmountPrice
5mg

Verified Test Results

Every batch, independently verified.

Each released batch is documented with its lot-specific certificate of analysis.

Latest COA

5-Amino-1MQ

Lot BPC-240118-AAA

97.4%

Purity by HPLC

Labeled5mg vial 5.08mg / vial5mg vial
Measured5.08mg / vial
Tested2026-06-19
View certificate
Full QC Panel Current released batch
Purity97.4%
Labeled Content5mg vial 5.08mg / vial5mg vial
Reported Content5.08mg / vial
EndotoxinClear
Batch Quantity1,000 vials

Every batch on record

Open any lot-specific certificate of analysis.

5-Amino-1MQ

Lot BPC-240118-AAA

Latest
97.4%

HPLC purity

Labeled
5mg vial 5.08mg / vial5mg vial
Measured
5.08mg / vial
Endotoxin
Clear
Tested
2026-06-19
View certificate

5-Amino-1MQ

Lot BPC-240118-A

97.4%

HPLC purity

Labeled
5mg vial 5.08mg / vial5mg vial
Measured
5.08mg / vial
Endotoxin
Clear
Tested
Jan 22, 2026
View certificate

Compound Information

Molecular Profile

What Is Tirzepatide?

A 39-residue synthetic linear peptide that acts as a dual agonist at both the GIP and GLP-1 receptors. A C20 fatty diacid chain at Lys-20 drives albumin binding for a once-weekly circulation profile.

Dual-Incretin Analog Albumin-Bound
Type
Dual GIP/GLP-1 receptor agonist
CAS Number
2023788-19-2
Molecular Formula
C225H348N48O68
Molecular Weight
4810.52 g/mol
Amino Acids
39
Modification
C20 fatty diacid at Lys-20
DrugBank Database

Storage Requirements

Stability Information

Freeze for storage Refrigerate after reconstitution Protect from light
Lyophilized (powder)Lyophiliz-20°C long-termed (powder)
Light protectionStore away from light